Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 1,362.00
+214.50 (18.69%)
At close: Feb 12, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 14.13 billion as of February 13, 2026. Its market cap has increased by 57.13% in one year.
Market Cap
14.13B
Enterprise Value
14.88B
Revenue
4.62B
Ranking
n/a
PE Ratio
24.97
Stock Price
1,362.00
Market Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 14.13B, an increase of 6,021.35%. That is a compound annual growth rate of 53.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 14.13B | 22.89% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 23.06B |
| Morepen Laboratories | 21.38B |
| Novartis India | 20.51B |
| Shukra Pharmaceuticals | 18.50B |
| Amrutanjan Health Care | 18.44B |
| TTK Healthcare | 13.44B |
| Syncom Formulations (India) | 13.39B |
| Lincoln Pharmaceuticals | 12.29B |